Claudia Pauligk
Claudia Pauligk publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Colorectal Cancer Treatments and Studies.
- World rank
- #401,742 of 7,710,434 ranked researchers
- Rank in Germany
- #19,765 of 364,343
- Works
- 198
- Citations
- 8.8k
- Citations per work
- 44.5
What does Claudia Pauligk research?
Claudia Pauligk's work is mostly in Medicine (81%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16181.1%
- Medicine16181.1%
- Everything else2412.3%
- Life Sciences136.6%
- 1Pulmonary and Respiratory Medicine30% of their works
- 2Oncology26% of their works
- 3Surgery16% of their works
- 4Gastroenterology9% of their works
- 5Cancer Research4% of their works
- 6Molecular Biology2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Treatments and Studies
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Which keywords describe Claudia Pauligk's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Neoadjuvant Therapy, Esophageal Carcinoma, Preoperative Chemoradiotherapy and Cetuximab.
- Taxanes
- PD-1 and PD-L1
- Targeted Therapy
- Surgical Complications
- Tumor Microenvironment
- Imatinib Mesylate
- Cetuximab
- Esophageal Carcinoma
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Neoadjuvant Therapy
- Preoperative Chemoradiotherapy
- KRAS Mutations
- Sunitinib
- Pancreatic Cancer
- EGFR Mutations
- Immune Checkpoint Blockade
- Chemotherapy-Induced Peripheral Neuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy2013 topics
- Endoscopic Resection1882 topics
- Gastric Cancer1241 topic
- Molecular Characterization1241 topic
- Neoadjuvant Therapy872 topics
- Esophageal Carcinoma641 topic
- Preoperative Chemoradiotherapy641 topic
- Cetuximab541 topic
- KRAS Mutations541 topic
- Imatinib Mesylate511 topic
- Sunitinib511 topic
- Tumor Microenvironment402 topics
- Pancreatic Cancer231 topic
- Surgical Complications231 topic
- EGFR Mutations191 topic
- Targeted Therapy191 topic
- Immune Checkpoint Blockade171 topic
- PD-1 and PD-L1171 topic
- Chemotherapy-Induced Peripheral Neuropathy151 topic
- Taxanes151 topic
Where does Claudia Pauligk work?
Claudia Pauligk's main affiliation in the publication record is Krankenhaus Nordwest, Germany.
How many publications and citations does Claudia Pauligk have?
OpenAlex counts 198 works and 8,805 citations for Claudia Pauligk, an h-index of 34, ranking #401,742 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Claudia Pauligk. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.